Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/11/2026 | $210.00 | Neutral → Overweight | Analyst |
| 3/11/2026 | $205.00 → $200.00 | Outperform | BMO Capital Markets |
| 3/11/2026 | $185.00 → $210.00 | Outperform | Oppenheimer |
| 2/25/2026 | $185.00 | Perform → Outperform | Oppenheimer |
| 2/9/2026 | Buy → Hold | Melius | |
| 2/9/2026 | $180.00 | Neutral → Buy | DA Davidson |
| 2/4/2026 | $270.00 → $205.00 | Outperform | BMO Capital Markets |
| 1/12/2026 | $240.00 | Buy | Goldman |
Analyst upgraded Oracle from Neutral to Overweight and set a new price target of $210.00
BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $200.00 from $205.00 previously
Oppenheimer reiterated coverage of Oracle with a rating of Outperform and set a new price target of $210.00 from $185.00 previously
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
10-Q - ORACLE CORP (0001341439) (Filer)
8-K - ORACLE CORP (0001341439) (Filer)
CERT - ORACLE CORP (0001341439) (Filer)
Automating draft note generation in emergency departments helps doctors sharpen focus on patients when every second counts LAS VEGAS, March 11, 2026 /PRNewswire/ -- HIMSS26 -- Oracle Health Clinical AI Agent note generation is now available in the U.S. for inpatient and emergency department settings. Designed to address the complex documentation needs of these environments, the solution automatically generates a comprehensive view of patient encounters, organizing symptoms and treatments into a single draft clinical note that reflects multiple clinical events and patient-clinician interactions.
Executive Advisory Board now includes more than 30 senior leaders from Fortune 500 and global enterprisesNEW YORK, March 11, 2026 /PRNewswire/ -- Myriad Venture Partners ("Myriad"), an early-stage venture capital firm focused on defining the future of business solutions in enterprise AI, enterprise B2B software, and industrial transformation, today announced the expansion of its Executive Advisory Board, bringing the Board to more than 30 C-suite leaders from Fortune 500 and global enterprises. New executives joining the Board include leaders from GSK, Mastercard, Harley-Davidson, Meta, Oracle, and other global companies, further strengthening Myriad's hands-on model and deepening its ties t
Q3 Remaining Performance Obligations $553 billion, up 325% year-over-year in USDQ3 GAAP Earnings per Share up 24% to $1.27, Non-GAAP Earnings per Share up 21% to $1.79Q3 Total Revenue $17.2 billion, up 22% in USD and up 18% in constant currencyQ3 Cloud Revenue (IaaS plus SaaS) $8.9 billion, up 44% in USD and up 41% in constant currency Q3 Cloud Infrastructure Revenue (IaaS) $4.9 billion, up 84% in USD and up 81% in constant currencyQ3 Oracle Cloud Database (IaaS) Revenue up 35%, Multicloud Database Revenue up 531% in USDQ3 Cloud Application (SaaS) Revenue $4.0 billion, up 13% in USD and up 11% in constant currencyQ3 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 17% in USD and up 14% in co
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
4 - ORACLE CORP (0001341439) (Issuer)
New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems can easily manage a broad range of interoperability services Early adopters see 50 percent reduction in processing times of Social Security Administration disability benefit claims AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle Health Connection Hub is now generally available for U.S. healthcare providers, enabling them to use a single console to more easily onboard, access, and manage preferences for Oracle Health interoperability solutions. The latest step in Oracle's strategy to increase interoperability and reduce friction between payers and pr
SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt
Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi
Q3 Remaining Performance Obligations $553 billion, up 325% year-over-year in USDQ3 GAAP Earnings per Share up 24% to $1.27, Non-GAAP Earnings per Share up 21% to $1.79Q3 Total Revenue $17.2 billion, up 22% in USD and up 18% in constant currencyQ3 Cloud Revenue (IaaS plus SaaS) $8.9 billion, up 44% in USD and up 41% in constant currency Q3 Cloud Infrastructure Revenue (IaaS) $4.9 billion, up 84% in USD and up 81% in constant currencyQ3 Oracle Cloud Database (IaaS) Revenue up 35%, Multicloud Database Revenue up 531% in USDQ3 Cloud Application (SaaS) Revenue $4.0 billion, up 13% in USD and up 11% in constant currencyQ3 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 17% in USD and up 14% in co
Earnings Results to be released on March 10, 2026, After the Close of the MarketAUSTIN, Texas, March 3, 2026 /PRNewswire/ -- Oracle Corporation today announced that its third quarter fiscal year 2026 results will be released on Tuesday, March 10th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results. The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About OracleOracle offers integrated suites of applications plus secure, autonomous infr
Q2 Remaining Performance Obligations $523 billion, up 438% in USDQ2 GAAP Earnings per Share up 91% to $2.10, Non-GAAP Earnings per Share up 54% to $2.26Q2 Total Revenue $16.1 billion, up 14% in USD and up 13% in constant currencyQ2 Cloud Revenue (IaaS plus SaaS) $8.0 billion, up 34% in USD and up 33% in constant currencyQ2 Cloud Infrastructure (IaaS) Revenue $4.1 billion, up 68% in USD and up 66% in constant currencyQ2 Cloud Application (SaaS) Revenue $3.9 billion, up 11% in both USD and constant currencyQ2 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 18% in USD and up 17% in constant currencyQ2 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 13% in both USD and constant currencyAUSTI
SC 13G/A - ORACLE CORP (0001341439) (Subject)
SC 13G/A - ORACLE CORP (0001341439) (Subject)
SC 13G/A - ORACLE CORP (0001341439) (Subject)